1.
Hebert A, Schrieber R, Glaab D, Eichenfield L. Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. J of Skin [Internet]. 2020Oct.27 [cited 2021Jan.25];4(6):s77. Available from: https://jofskin.org/index.php/skin/article/view/1110